Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioMarket CapitalizationNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Capital Employed: 2018-2024

Historic Return on Capital Employed for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to -0.56%.

  • Solid Biosciences' Return on Capital Employed rose 9.00% to -0.56% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.56%, marking a year-over-year increase of 9.00%. This contributed to the annual value of -0.53% for FY2023, which is 5.00% down from last year.
  • Solid Biosciences' Return on Capital Employed amounted to -0.56% in Q3 2024, which was down 27.08% from -0.44% recorded in Q2 2024.
  • Over the past 5 years, Solid Biosciences' Return on Capital Employed peaked at -0.44% during Q2 2024, and registered a low of -2.88% during Q3 2020.
  • Over the past 3 years, Solid Biosciences' median Return on Capital Employed value was -0.51% (recorded in 2022), while the average stood at -0.54%.
  • Data for Solid Biosciences' Return on Capital Employed shows a peak YoY increase of 12bps (in 2020) and a maximum YoY decrease of 175bps (in 2020) over the last 5 years.
  • Over the past 4 years, Solid Biosciences' Return on Capital Employed (Quarterly) stood at -1.09% in 2020, then reached -0.51% in 2022, then dropped by 14bps to -0.65% in 2023, then rose by 9bps to -0.56% in 2024.
  • Its Return on Capital Employed was -0.56% in Q3 2024, compared to -0.44% in Q2 2024 and -0.51% in Q1 2024.